News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sorin Group S.p.A. (SRN) Invests in Cardiosolutions, a Development-Stage Company Focused on Mitral Valve Technology


7/10/2012 10:39:50 AM

AN--(BUSINESS WIRE)--Sorin Group (MIL:SRN)(Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today a minority investment in Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES